With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Impact of Pediatric Germline Testing in a Pediatric Cancer Predisposition Clinic||Children's Hospital of Philadelphia / Lisa Schwartz, PhD||Psychosocial Family Impact Grant||2018||Pennsylvania|
|Surviving Cancer CAMPetently: Evidence-based Care Delivered at Family Camp||Nemours A.I. duPont Hospital for Children / Melissa Alderfer, PhD||Psychosocial Family Impact Grant||2018||Delaware|
|Enhancing Communication about Sexual and Reproductive Health between Oncology Clinicians and Adolescent and Young Adults||Connecticut Children's Medical Center / Dr. Natasha Frederick, PhD||Psychosocial Launch Grant||2018||Connecticut|
|Interrogation of Neuroblastoma Dependencies and RNAs on the Core-Regulatory Circuitry for Therapeutic Inhibition||St. Jude Children's Research Hospital / Adam Durbin, PhD||Young Investigator Grants||2018||Tennessee|
|Pedi-PRESTO: Pediatric Patient-Reported Symptom Tracking in Oncology||Children's Hospital of Philadelphia / Allison Barz Leahy, MD||Young Investigator Grants||2018||Pennsylvania|
|Beyond Febrile Neutropenia: Risks Associated with Antibiotic Choice in Children with Leukemia that Undergo Transplant||Children's Hospital of Philadelphia / Caitlin Elgarten, MD||Young Investigator Grants||2018||Pennsylvania|
|Cooperating Signaling Networks Regulate Cell Survival of Pediatric Ph-like ALL||University of Pennsylvania / Christian Hurtz, PhD||Young Investigator Grants||2018||Pennsylvania|
|Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution||Massachusetts General Hospital / Chuan Yan, PhD||Young Investigator Grants||2018||Massachusetts|
|Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy||Fred Hutchinson Cancer Research Center / Colin Godwin, MD||Young Investigator Grants||2018||Washington|
|Describing the Biological Impacts of Gain-of-function SAMD9 Mutations||Vanderbilt University Medical Center / Jason Schwartz, MD/PhD||Young Investigator Grants||2018||Tennessee|